11/1/2023 12:28:28 PM - Gapped down today consolidating just above its 50 and 200 DMA lines. Reported Sep &#39;23 quarterly earnings +6% on +16% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.<br><hr>10/16/2023 12:39:24 PM - Rebounding toward its all-time high making progress above its 50 and 200 DMA lines. Reported Jun &#39;23 quarterly earnings +2% on +13% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.<br><hr>11/11/2022 12:27:22 PM - Abruptly retreating from its all-time high with today&#39;s big volume-driven loss. Its 50 DMA line ($509.50) defines near-term support to watch. The 11/03/22 mid-day report noted - <i>"Reported Sep &#39;22 quarterly earnings +42% on +10% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>11/3/2022 12:32:58 PM - Extended from any sound base and perched at its all-time high with today&#39;s gain adding to a spurt of volume-driven gains after consolidating above its 50 DMA line. Reported Sep &#39;22 quarterly earnings +42% on +10% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.<br><hr>10/25/2022 1:11:07 PM - Powering to a new all-time high with today&#39;s 4th consecutive volume-driven gain after consolidating above its 50 DMA line ($494). Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>10/10/2022 12:21:33 PM - Perched near its all-time high and consolidating above its 50 DMA line ($489.56). Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/30/2022 12:00:48 PM - Perched near its all-time high and consolidating above its 50 DMA line ($488). Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/28/2022 12:22:24 PM - Retreated from a new all-time high hit last week and it is consolidating near its 50 DMA line ($487.50). Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/26/2022 12:42:26 PM - Retreated from a new all-time high hit last week and slumped back below its 50 DMA line ($487.61). Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/23/2022 12:40:50 PM - Retreating from a new all-time high hit this week and slumping back below its 50 DMA line ($487.62) with today&#39;s loss. Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/20/2022 12:36:23 PM - Hitting a new all-time high with today&#39;s gap up and 4th consecutive gain after rebounding above its 50 DMA line. Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>9/15/2022 1:06:00 PM - Gapped up today rebounding above its 50 DMA line ($485.62) toward its all-time high. Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>7/27/2022 12:43:32 PM - Gapped down today pulling back from its all-time high. Reported Jun &#39;22 quarterly earnings +26% on +15% sales revenues versus the year ago period. Noted with caution in prior mid-day reports - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>7/25/2022 12:37:41 PM - Hovering near its all-time high and stubbornly holding its ground since last noted with caution in the 7/15/22 mid-day report - <i>"Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong."</i><br><hr>7/15/2022 12:53:27 PM - Gapped up today challenging its all-time high, on track for its 4th consecutive weekly gain. Quarterly comparisons through Mar &#39;22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.<br><hr>11/4/2020 12:26:37 PM - Gapped up today hitting a new all-time high. Rebounded above its 50 DMA line with recent volume-driven gains. Reported earnings -39% on +24% sales revenues for the Sep &#39;20 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Went through a deep pullback and rebounded impressively since noted with caution in the 3/09/20 mid-day report.<br><hr>9/22/2020 12:14:50 PM - Recently slumped below its 50 DMA line and it acted as resistance when trying to rebound. Reported earnings +108% on +17% sales revenues for the Jun &#39;20 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Went through a deep pullback and rebounded impressively since last noted with caution in the 3/09/20 mid-day report.<br><hr>9/11/2020 12:20:11 PM - Slumping below its 50 DMA line. Reported earnings +108% on +17% sales revenues for the Jun &#39;20 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Went through a deep pullback and rebounded impressively since last noted with caution in the 3/09/20 mid-day report.<br><hr>3/9/2020 12:40:50 PM - Rebounded impressively after recently testing its 200 DMA line, but it is slumping below its 50 DMA line again with today&#39;s 3rd consecutive volume-driven loss. Reported earnings -14% on +15% sales revenues for the Dec &#39;19 quarter, its 2nd comparison below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>3/5/2020 12:32:02 PM - Quickly rebounded near its all-time high after abruptly retreating to test its 200 DMA line. Reported earnings -14% on +15% sales revenues for the Dec &#39;19 quarter, its 2nd comparison below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>3/4/2020 11:06:59 AM - Rebounding near its all-time high after abruptly retreating to test its 200 DMA line. Reported earnings -14% on +15% sales revenues for the Dec &#39;19 quarter, its 2nd comparison below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>1/9/2020 12:06:33 PM - Hovering near its all-time high since last noted with caution in the 12/16/19 mid-day report - <i>&quot;Reported earnings +10% on +14% sales revenues for the Sep &#39;19 quarter, below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.&quot; </i><br><hr>12/16/2019 12:37:19 PM - Hitting a new all-time high with today&#39;s volume-driven gain following a streak of gains with light volume. Stubbornly held its ground and made steady progress since last noted with caution in the 11/18/19 mid-day report - <i>&quot;Reported earnings +10% on +14% sales revenues for the Sep &#39;19 quarter, below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.&quot; </i><br><hr>11/18/2019 12:13:52 PM - Rebounded near its all-time high following a deep slump since last noted with caution in the 12/17/18 mid-day report. Reported earnings +10% on +14% sales revenues for the Sep &#39;19 quarter, below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.<br><hr>12/17/2018 12:47:44 PM - Below its 200 DMA line ($308). Retreated abruptly following a spike to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>12/6/2018 12:18:53 PM - Again retreating near its 200 DMA line ($307). Retreated abruptly following a spike to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/28/2018 12:52:25 PM - Rebounding near its 50 DMA line ($326) with today&#39;s big gain after finding support near its 200 DMA line ($306). Retreated abruptly following a spike to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/27/2018 12:53:22 PM - Finding support near its 200 DMA line ($305). Retreated abruptly following a spike to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/21/2018 12:47:51 PM - Finding support at its 200 DMA line ($305.20) after retreating abruptly following a spike to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/20/2018 12:30:44 PM - Testing its 200 DMA line ($304.98) with today&#39;s loss, retreating abruptly after spiking to a new all-time high with a big volume-driven gain on 11/07/18. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/14/2018 12:40:41 PM - Retreating below its 50 DMA line with today&#39;s 5th consecutive volume-driven loss after spiking to a new all-time high with a big volume-driven gain on 11/07/18 capping a 5 session winning streak. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>11/8/2018 11:55:11 AM - Retreating today after spiking to new all-time highs with a big volume-driven gain on the prior session capping a 5 session winning streak. Reported earnings +35% on +7% sales revenues for the Sep &#39;18 quarter. Sub par sales revenues growth raises fundamental concerns. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>8/2/2017 12:13:08 PM - Gapped up today rebounding above its 50 DMA line. Reported earnings +6% on -3% sales revenues for the Jun &#39;17 quarter. Sub par sales revenues growth raises fundamental concerns. Its quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>12/5/2016 12:27:33 PM - Pulling back for a 2nd consecutive session after an impressive streak of volume-driven gains challenging its 2015 all-time high. Sub par sales revenues growth raises fundamental concerns. Its quarterly and annual earnings (C and A criteria) history also is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>2/27/2012 12:30:31 PM - Consolidating near its 50 DMA line today. Endured distributional pressure while prior mid-day reports noted - <em>&quot;Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>2/21/2012 12:55:31 PM - Rallying back above its 50 DMA line today. While enduring distributional pressure prior mid-day reports noted - <em>&quot;Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>1/25/2012 12:22:51 PM - Traded under its 50 DMA line today following a gap down while enduring distributional pressure. Prior mid-day reports noted - <em>&quot;Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>1/20/2012 12:12:52 PM - Pulling back from the new all-time high hit earlier this week. Showed bullish action above its 50 DMA line since noted in the 11/01/11 mid-day report after technically breaking out of a <strong>17</strong>-week &quot;double bottom&quot; base pattern during which it found support near its 200 DMA line - <em>&quot;Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>1/6/2012 1:02:08 PM - Volume-driven gains for a <strong>4</strong>th consecutive session have it surging to new all-time highs this week.  Showed bullish action above its 50 DMA line since last noted in the 11/01/11 mid-day report after technically breaking out of a <strong>17</strong>-week &quot;double bottom&quot; base pattern during which it found support near its 200 DMA line - <em>&quot;Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>11/1/2011 12:57:06 PM - Pulling back today following a 10/31/11 gap up and volume-driven gain for new 52-week and all-time highs while technically breaking out of a <strong>17</strong>-week double bottom base pattern during which it found support near its 200 DMA line. Reported earnings <strong>+13%</strong> on <strong>+11%</strong> sales revenues for the quarter ended September 30, 2011 versus the year ago period. Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Prior mid-day reports noted - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>10/31/2011 12:25:20 PM - Gapped up today, hitting new 52-week and all-time highs while technically breaking out of a <strong>17</strong>-week double bottom base pattern during which it found support near its 200 DMA line. Reported earnings <strong>+13%</strong> on <strong>+11%</strong> sales revenues for the quarter ended September 30, 2011 versus the year ago period. Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Last noted in the 10/24/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>10/24/2011 1:44:19 PM - Gapped up today challenging prior highs and its 52-week high. Strength and leadership (<strong>L</strong> criteria) in the HMO group is a reassuring sign. Last noted in the 7/07/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>7/7/2011 12:25:39 PM - Pulling back from its 52-week high today. It has been quietly approaching its 2008 all-time high amid strength in the HMO group. Last noted in the 6/22/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>6/22/2011 12:57:01 PM - Hitting a new 52-week high today with a <strong>3</strong>rd consecutive gain, quietly approaching its 2008 all-time high. Amid strength in the HMO group it was last noted in the 6/09/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>6/9/2011 12:56:52 PM - Hovering near its 52-week high, trading up today amid strength in the HMO group. Last noted in the 5/26/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>5/26/2011 12:58:19 PM - Hovering near its 52-week high today. Last noted in the 4/27/11 mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>4/27/2011 12:49:47 PM - Hovering near its 52-week high today. Gapped up on 4/26/11 and it was noted in the mid-day report - <em>&quot;Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.&quot; </em><br><hr>4/26/2011 12:36:45 PM - Hit a new 52-week high after gapping up today. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.<br><hr>11/2/2010 12:37:04 PM - Hitting yet another new 52-week high after gapping up today. Sub par sales revenues and quarterly earnings increases raise fundamental concerns. Its annual earnings history is marred by a downturn in FY &#39;08 earnings after years of steady growth.<br><hr>11/1/2010 12:33:54 PM - Steadily inching up for new 52-week highs since its last mid-day report appearance on 10/15/10 when it was noted - <em>&quot;Sub par sales revenues increases and its up and down annual earnings history raise fundamental concerns. Group leadership (the <strong>L</strong> criteria) has been a factor helping many healthcare companies in recent weeks, meanwhile policy-makers have met behind closed doors to negotiate healthcare reform plans which will impact the industry.&quot; </em><br><hr>10/15/2010 1:18:12 PM - Hovering near its 52-week high today after <strong>6</strong> consecutive gains capped off with a spurt of heavy volume. This week marked its first mid-day report appearances since 1/21/10 when it was noted - <em>&quot;Sub par sales revenues increases and its up and down annual earnings history raise fundamental concerns. Group leadership (the <strong>L</strong> criteria) has been a factor helping many healthcare companies in recent weeks, meanwhile policy-makers have met behind closed doors to negotiate healthcare reform plans which will impact the industry.&quot; </em><br><hr>10/14/2010 12:47:10 PM - Hit a new 52-week high today with its <strong>6</strong>th consecutive gain, marking its first mid-day report appearance since 1/21/10 when it was noted - <em>&quot;Sub par sales revenues increases and its up and down annual earnings history raise fundamental concerns. Group leadership (the <strong>L</strong> criteria) has been a factor helping many healthcare companies in recent weeks, meanwhile policy-makers have met behind closed doors to negotiate healthcare reform plans which will impact the industry.&quot; </em><br><hr>1/21/2010 12:58:33 PM - Perched near its 52-week high while making its <strong>4</strong>th mid-day report appearance of 2010. Sub par sales revenues increases and its up and down annual earnings history raise fundamental concerns.  Group leadership (the <strong>L</strong> criteria) has been a factor helping many healthcare companies in recent weeks, meanwhile policy-makers have met behind closed doors to negotiate healthcare reform plans which will impact the industry.<br><hr>1/20/2010 1:19:45 PM - Reversed into the red today after early gains for another new 52-week high following its 1/19/10 mid-day report appearance. Group leadership (the <strong>L</strong> criteria) has been a factor helping many healthcare companies in recent weeks while policy-makers have met behind closed doors to negotiate healthcare reform plans which will impact the industry.<br><hr>1/19/2010 12:38:06 PM - Gapped up today, rallying to a new 52-week high. Group leadership (the <strong>L</strong> criteria) is a factor helping it and many other healthcare companies today.<br><hr>1/14/2008 12:41:27 PM - Started 2008 with technically strong action that has lifted it to new all-time highs, and it is now extended  from prior chart highs that were resistance in the $80 area. Last noted on 10/29/07 when it negatively reversed after early gains.  Strong earnings history satisfies the C and A criteria.   Group strength is helping it along with many other healthcare companies, which are  considered defensive plays.<br><hr>10/29/2007 12:34:35 PM - Negatively reversed after early gains. Wide intra-day price swings in recent days are a sign of uncertainty. Earnings report and conference call due on the morning of 10/29/07. Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs that were resistance in the $68 area.<br><hr>10/26/2007 1:39:39 PM - Wide intra-day price swings in recent days are a sign of uncertainty. Earnings report and conference call due on the morning of 10/29/07. Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs that were resistance in the $68 area.<br><hr>10/25/2007 1:39:32 PM - Repairing its considerable 10/24/07 loss. Earnings report and conference call due on the morning of 10/29/07. Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs that were resistance in the $68 area.<br><hr>10/24/2007 12:54:34 PM - Considerable loss on above average volume. Earnings report and conference call due on the morning of 10/29/07. Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs that were resistance in the $68 area.<br><hr>10/23/2007 1:01:35 PM - Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs that were resistance in the $68 area.<br><hr>10/22/2007 12:34:49 PM - Strong earnings history satisfies the C and A criteria.  Extended a bit from prior chart highs in the $68 area.<br><hr>7/19/2006 12:34:34 PM - With the last quarter being reported -2% that makes the "C" below guidelines.<br><hr>7/11/2006 12:48:52 PM - With the last quarter being reported -2% that makes the "C" below guidelines.<br><hr>2/2/2006 12:52:19 PM - "C" below guidelines.<br><hr>1/19/2006 12:36:06 PM - "C" below guidelines.<br><hr>1/13/2006 12:27:39 PM - "C" below guidelines.<br><hr>1/5/2006 2:03:18 PM - "C" below guidelines.<br><hr>1/4/2006 1:09:39 PM - "C" below guidelines.<br><hr>1/3/2006 12:51:23 PM - "C" below guidelines.<br><hr>12/27/2005 12:43:30 PM - "C" below guidelines.<br><hr>12/23/2005 1:07:07 PM - "C" below guidelines.<br><hr>12/22/2005 12:50:55 PM - "C" below guidelines.<br><hr>9/30/2005 12:32:59 PM - 'C' below guidelines.<br /><br><hr>5/31/2005 - Highlighted on 1/28/2004 in <a href="/cnnews/middaycbor/middaybreakoutstodaypay012804.asp">CANSLIM.net's Mid-Day Breakouts Report</a>. Has been base building since. Now is pearched near all time highs.<br><hr>5/4/2005 12:27:28 PM - G - First appeared in our reports on 1/28/04 at $23.78. Has moved higher since. It is now building a new base.                                                                                                                                                                                                                                                                                                                                                                                                      <br><hr>2/7/2005 12:35:44 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Has moved higher since. It is now building a new base.                                                                                                                                                                                                                                                                                                                                                                                                     <br><hr>1/25/2005 12:30:31 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Has moved higher since. It is now building a new base.                                                                                                                                                                                                                                                                                                                                                                                                     <br><hr>1/24/2005 12:44:15 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Has moved higher since. It is now pulling back towards PP. Overall market is weak. Becareful not to let any "winners" turn into losers. Building a new base.                                                                                                                                                                                                                                                                                               <br><hr>1/20/2005 12:39:30 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Has moved higher since. It is now pulling back towards PP. Overall market is weak. Becareful not to let any "winners" turn into losers.                                                                                                                                                                                                                                                                                                                    <br><hr>1/19/2005 12:38:00 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. Gapped higher last week on above average volume. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                            <br><hr>1/18/2005 12:47:33 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. Gapped higher last week on above average volume. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                            <br><hr>1/13/2005 12:28:47 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. Gapped higher today on above average volume. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                <br><hr>1/12/2005 12:22:30 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                                                             <br><hr>1/11/2005 12:22:15 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                                                             <br><hr>1/10/2005 12:36:28 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                                                             <br><hr>1/6/2005 12:29:55 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                                                             <br><hr>12/14/2004 12:20:38 PM - G - First made noteworthy (yellow) on 1/28/04 at $23.78. Now too ET from a sound base of support at this point to be considered buyable under the guidelines. NOTE: Watch for stocks highlighted in yellow as these are the better CANSLIM-based buy candidates. Once they become green they are considered to be too extended under the guidelines. 
                                                                                                                                                             <br><hr>1/28/2004 1:00:00 PM - Y - L in just okay group. Nice "A" and holding stubbornly to its 01/20/04 gap up gains since it rebounded above its 50 DMA.                                                                                                                                                                                                                                                                                                                                                                                         <br><hr>